Clinical Trial Update: Evaluation of rhGH Replacement Therapy in Patients With Pseudohypoparathyroidism Type Ia (PHP Ia) [NA]

View source ↗

Summary

An update on a clinical trial evaluating recombinant human growth hormone replacement therapy in patients with Pseudohypoparathyroidism Type Ia (PHP Ia).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dwarfism
• Growth Hormone Deficiency
• Pseudohypoparathyroidism

Drugs mentioned

• Somatropin (somatropin)

Snippet

Sponsor: University of Milan | Conditions: Pseudohypoparathyroidism, Growth Hormone Deficiency, Dwarfism | NA | Status: UNKNOWN